Drugs and Devices

FDA approves new drugs

  • ·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with advanced colorectal cancer who are no longer responding to other therapies. Read more
  • On Sept. 17, the FDA approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults. Read more

Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares